HQH
Income statement / Annual
Last year (2023), Tekla Healthcare Investors's total revenue was $58.12 M,
a decrease of 130.23% from the previous year.
In 2023, Tekla Healthcare Investors's net income was $56.33 M.
See Tekla Healthcare Investors’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
09/30/2015 |
09/30/2014 |
| Operating Revenue |
$58.12 M
|
-$192.26 M
|
$157.10 M
|
$242.92 M
|
-$143.63 M
|
$70.97 M
|
$123.06 M
|
$55.06 M
|
$4.33 M
|
$2.14 M
|
| Cost of Revenue |
$10.90 M |
$11.30 M |
$12.17 M |
$10.42 M |
$10.02 M |
$10.39 M |
$10.24 M |
$10.67 M |
$0.00 |
$0.00 |
| Gross Profit |
$47.22 M |
-$203.56 M |
$144.93 M |
$232.50 M |
-$153.65 M |
$60.58 M |
$112.83 M |
$44.39 M |
$4.33 M |
$2.14 M |
| Gross Profit Ratio |
0.81 |
1.06 |
0.92 |
0.96 |
1.07 |
0.85 |
0.92 |
0.81 |
1 |
1 |
| Research and Development
Expenses |
$0.56
|
-$2.60
|
$1.74
|
$2.62
|
-$1.69
|
$0.91
|
$1.40
|
-$1.02
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$1.24 M
|
$1.40 M
|
$1.30 M
|
$1.17 M
|
$1.14 M
|
$1.21 M
|
$1.23 M
|
$11.08 M
|
$12.18 M
|
$9.30 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$1.24 M
|
$1.40 M
|
$1.30 M
|
$1.17 M
|
$1.14 M
|
$1.21 M
|
$1.23 M
|
-$1.02
|
$12.18 M
|
$9.30 M
|
| Other Expenses |
-$33.21 M |
-$257.59 M |
$78.34 M |
$159.63 M |
-$221.25 M |
$42.22 M |
$40.65 M |
$39.00 M |
$0.00 |
$0.00 |
| Operating Expenses |
$1.78 M |
$1.96 M |
$1.93 M |
$1.72 M |
$1.66 M |
$1.77 M |
$1.78 M |
$60.82 M |
$91.83 M |
$219.87 M |
| Cost And Expenses |
$1.78 M |
$1.96 M |
$1.93 M |
$1.72 M |
$1.66 M |
$1.77 M |
$1.78 M |
$44.39 M |
$91.83 M |
$219.87 M |
| Interest Income |
$620,013.00 |
$112,314.00 |
$0.00 |
$265,106.00 |
$287,578.00 |
$119,891.00 |
$104,178.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.19 M
|
$3.67 M
|
$6.23 M
|
$1.97 M
|
$2.87 M
|
$4.12 M
|
$5.16 M
|
$6.28 M
|
$7.85 M
|
$7.16 M
|
| EBITDA |
$56.33 M
|
-$194.23 M
|
$155.18 M
|
$241.20 M
|
-$145.29 M
|
$69.20 M
|
$121.28 M
|
$111.08 M
|
$104.02 M
|
$229.17 M
|
| EBITDA Ratio |
0.97 |
1.01 |
0.99 |
0.99 |
1.01 |
0.98 |
0.99 |
2.02 |
24.01 |
106.89 |
| Operating Income Ratio
|
0.97
|
1.01
|
0.99
|
0.99
|
1.01
|
0.98
|
0.99
|
-0.11
|
-1.81
|
-3.34
|
| Total Other
Income/Expenses Net |
-$3,952.00
|
$5,477.00
|
-$17,797.00
|
-$25,296.00
|
$7,228.00
|
$1.64
|
$2.98
|
-$1.44
|
$104.02 M
|
$229.17 M
|
| Income Before Tax |
$56.33 M |
-$194.23 M |
$155.18 M |
$241.20 M |
-$145.29 M |
$69.20 M |
$121.28 M |
-$56.02 M |
$96.17 M |
$222.02 M |
| Income Before Tax Ratio
|
0.97
|
1.01
|
0.99
|
0.99
|
1.01
|
0.98
|
0.99
|
-1.02
|
22.2
|
103.55
|
| Income Tax Expense |
-$1.19 M |
-$3.66 M |
-$6.25 M |
-$2.00 M |
-$2.86 M |
-$161,141.00 |
-$5.16 M |
$160.82 M |
$104.02 M |
$229.17 M |
| Net Income |
$56.33 M |
-$194.23 M |
$155.18 M |
$241.20 M |
-$145.29 M |
$69.20 M |
$121.28 M |
-$56.02 M |
$96.17 M |
$222.02 M |
| Net Income Ratio |
0.97 |
1.01 |
0.99 |
0.99 |
1.01 |
0.98 |
0.99 |
-1.02 |
22.2 |
103.55 |
| EPS |
1.14 |
-4.1 |
3.49 |
5.5 |
-3.39 |
1.53 |
2.99 |
1 |
2.58 |
6.2 |
| EPS Diluted |
1.14 |
-4.1 |
3.49 |
5.5 |
-3.39 |
1.53 |
2.99 |
39002429 |
2.58 |
6.2 |
| Weighted Average Shares
Out |
$49.44 M
|
$47.34 M
|
$44.46 M
|
$43.87 M
|
$42.83 M
|
$45.23 M
|
$40.56 M
|
-$56.02 M
|
$37.30 M
|
$35.82 M
|
| Weighted Average Shares
Out Diluted |
$49.44 M
|
$47.34 M
|
$44.46 M
|
$43.87 M
|
$42.83 M
|
$45.23 M
|
$40.56 M
|
-$1.44
|
$37.30 M
|
$35.82 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
